These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 16101740

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
    Yu P, Huang L, Zou J, Yu Z, Wang Y, Wang X, Xu L, Liu X, Xu XM, Lu PH.
    Neurobiol Dis; 2008 Dec; 32(3):535-42. PubMed ID: 18930141
    [Abstract] [Full Text] [Related]

  • 3. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE, Liu BP, Park JH, Strittmatter SM.
    Neuron; 2004 Oct 28; 44(3):439-51. PubMed ID: 15504325
    [Abstract] [Full Text] [Related]

  • 4. Resistance of interleukin-6 to the extracellular inhibitory environment promotes axonal regeneration and functional recovery following spinal cord injury.
    Yang G, Tang WY.
    Int J Mol Med; 2017 Feb 28; 39(2):437-445. PubMed ID: 28075461
    [Abstract] [Full Text] [Related]

  • 5. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
    Li S, Liu BP, Budel S, Li M, Ji B, Walus L, Li W, Jirik A, Rabacchi S, Choi E, Worley D, Sah DW, Pepinsky B, Lee D, Relton J, Strittmatter SM.
    J Neurosci; 2004 Nov 17; 24(46):10511-20. PubMed ID: 15548666
    [Abstract] [Full Text] [Related]

  • 6. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
    Li S, Strittmatter SM.
    J Neurosci; 2003 May 15; 23(10):4219-27. PubMed ID: 12764110
    [Abstract] [Full Text] [Related]

  • 7. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat.
    Cao Y, Shumsky JS, Sabol MA, Kushner RA, Strittmatter S, Hamers FP, Lee DH, Rabacchi SA, Murray M.
    Neurorehabil Neural Repair; 2008 May 15; 22(3):262-78. PubMed ID: 18056009
    [Abstract] [Full Text] [Related]

  • 8. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.
    Guo X, Zahir T, Mothe A, Shoichet MS, Morshead CM, Katayama Y, Tator CH.
    Cell Transplant; 2012 May 15; 21(6):1177-97. PubMed ID: 22236767
    [Abstract] [Full Text] [Related]

  • 9. Delayed Nogo receptor therapy improves recovery from spinal cord contusion.
    Wang X, Baughman KW, Basso DM, Strittmatter SM.
    Ann Neurol; 2006 Nov 15; 60(5):540-549. PubMed ID: 16958113
    [Abstract] [Full Text] [Related]

  • 10. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury.
    Li S, Kim JE, Budel S, Hampton TG, Strittmatter SM.
    Mol Cell Neurosci; 2005 May 15; 29(1):26-39. PubMed ID: 15866044
    [Abstract] [Full Text] [Related]

  • 11. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
    GrandPré T, Li S, Strittmatter SM.
    Nature; 2002 May 30; 417(6888):547-51. PubMed ID: 12037567
    [Abstract] [Full Text] [Related]

  • 12. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice.
    Steward O, Sharp K, Yee KM, Hofstadter M.
    Exp Neurol; 2008 Feb 30; 209(2):446-68. PubMed ID: 18234196
    [Abstract] [Full Text] [Related]

  • 13. Soluble cell adhesion molecule L1-Fc promotes locomotor recovery in rats after spinal cord injury.
    Roonprapunt C, Huang W, Grill R, Friedlander D, Grumet M, Chen S, Schachner M, Young W.
    J Neurotrauma; 2003 Sep 30; 20(9):871-82. PubMed ID: 14577865
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey.
    Freund P, Wannier T, Schmidlin E, Bloch J, Mir A, Schwab ME, Rouiller EM.
    J Comp Neurol; 2007 Jun 01; 502(4):644-59. PubMed ID: 17394135
    [Abstract] [Full Text] [Related]

  • 18. The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats.
    Wang YT, Lu XM, Zhu F, Huang P, Yu Y, Zeng L, Long ZY, Wu YM.
    Biomaterials; 2011 Nov 01; 32(31):7988-98. PubMed ID: 21784510
    [Abstract] [Full Text] [Related]

  • 19. Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury.
    Chan CC, Khodarahmi K, Liu J, Sutherland D, Oschipok LW, Steeves JD, Tetzlaff W.
    Exp Neurol; 2005 Dec 01; 196(2):352-64. PubMed ID: 16154567
    [Abstract] [Full Text] [Related]

  • 20. Nogo receptor decoy promotes recovery and corticospinal growth in non-human primate spinal cord injury.
    Wang X, Zhou T, Maynard GD, Terse PS, Cafferty WB, Kocsis JD, Strittmatter SM.
    Brain; 2020 Jun 01; 143(6):1697-1713. PubMed ID: 32375169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.